• S&P 500: 1,342.64
  • Change: -0.69%
$1.00 -0.04 (-3.37%)
2/10/2012 4:00 PM

Peregrine Pharmaceuticals (NASDAQ:PPHM)

CAPS Rating: 3 out of 5

A biopharmaceutical company with a portfolio of clinical stage and pre-clinical product candidates using monoclonal antibodies for the treatment of cancer and viral diseases.

Current Price $1.00 Mkt Cap $79.93M
Open $1.03 P/E Ratio 0.00
Prev. Close $1.04 Div. (Yield) N/A (N/A)
Daily Range $0.99 - $1.03 Volume 1,462,746
52-Wk Range $0.85 - $2.74 Avg. Daily Vol. 0

News & Discussion Boards

Caps

How do you think PPHM will perform against the market?

You must Sign in to MSN Caps before you can make a call.

All Players

86 Outperform
5 Underperform
 

All-Star Players

19 Outperform
1 Underperform
 

Wall Street

1 Outperform
0 Underperform
 

Top PPHM Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

azurlo (< 20)
Submitted February 10, 2011

Strong late stage pipeline

Add Comment | Reply | Report this Post

AjarnMichael (25.77)
Submitted May 10, 2010

F

1 Comment | Reply | Report this Post
PPHM VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about PPHM.

Recs

0
Member Avatar dbassett12 (90.88) Submitted: 12/18/2011 4:16:37 PM : Outperform Start Price: $0.96 PPHM Score: -5.27

following ZZ. Hoping to find resistance near the 52 week low.

Report this Post 1 Comment | Reply | Permalink

Recs

0
Member Avatar zzlangerhans (99.27) Submitted: 12/14/2011 12:30:25 AM : Outperform Start Price: $1.06 PPHM Score: -14.57

I guessed correctly that Peregrine's jump on preliminary first-line NSCLC data wouldn't be sustained and skipped out close to the high. But I'm surprised to see the stock close to the recent low of 0.9 so quickly. It looks like bavituximab doesn't have too many believers, and I'm in the skeptical camp myself. I do think the company will be able to pull some more positives out of the ongoing controlled phase II trials before bavituximab eventually sinks into quicksand like its compadre Cotara. I'm going to keep playing the volatility and cement my score leadership.

Report this Post Add Comment | Reply | Permalink

Recs

0
Member Avatar KimLanners (< 20) Submitted: 7/13/2011 6:38:29 PM : Outperform Start Price: $2.26 PPHM Score: -57.19

biot

Report this Post Add Comment | Reply | Permalink
View All 12 Pitches »

Leaderboard

Find the members with the highest scoring picks in PPHM.

Score Leader

AjarnMichael

AjarnMichael (25.77) Score: +89.00

The Score Leader is the player with the highest score across all their picks in PPHM.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		Index
Gain 		Score Commentary
AjarnMichael 25.77 5/10/2010 Underperform 5Y $3.72 -72.98% +16.02% +89.00 2 Comments
octoberfast 90.61 10/15/2010 Underperform 5Y $1.64 -38.72% +13.60% +52.32 0 Comment
c0stroks 63.74 11/1/2010 Underperform 3M $1.51 -33.44% +12.84% +46.29 0 Comment
golfsd27 < 20 8/16/2011 Underperform 3M $1.45 -30.64% +11.99% +42.63 0 Comment
Lordrobot 90.11 1/18/2012 Outperform 3Y $0.91 +10.44% +3.91% +6.53 0 Comment
RCotner < 20 1/17/2012 Outperform 1Y $0.92 +9.24% +3.29% +5.95 0 Comment
chsch853 < 20 2/6/2012 Outperform 3M $1.00 +0.50% +0.28% +0.22 0 Comment
doubleoverhead 94.06 2/6/2012 Outperform 5Y $1.00 +0.50% +0.28% +0.22 0 Comment
EvilEmpire 94.76 2/3/2012 Outperform 5Y $1.02 -1.47% +0.27% -1.74 0 Comment
MichaelMiele 88.15 1/23/2012 Outperform NS $1.02 -1.47% +2.22% -3.69 0 Comment
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackJMP 84.95 8/30/2011 Outperform NS $1.45 -30.69% +11.46% -42.15 0 Comment

Featured Broker Partners